The Recall Desk
ModerateFDA (Devices)·Z-1273-2014·Announced 2014-04-02

Spacelabs Recalls G2 Clinical Access Software CDs Due to Incorrect Programs

Spacelabs Healthcare is voluntarily recalling G2 Clinical Access Software CDs because they contain incorrect programs, preventing customers from installing the software.

What this means for you

Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.

Our severity reasoning: The recall is a voluntary precautionary action for a software installation defect that prevents software installation but does not pose a direct physical safety hazard or report injuries.

Plain-English summary

Spacelabs Healthcare, LLC has voluntarily recalled G2 Clinical Access Software CDs. The affected products include the G2 Clinical Access CD (Part Number: 063-1829-11 Rev A) and the Update Kit (Part Number: 040-1565-10). These CDs are used for installing ICS G2 Clinical Access software onto hospital personal computers.

The recall was initiated because the programs installed on the Clinical Access CD are incorrect. This defect prevents customers from successfully installing the Clinical Access software. The agency classification for this recall is Class II.

A total of 36 units were distributed worldwide, with 17 units distributed in the United States and 19 units distributed outside the United States. The US distribution included Alabama, Florida, Georgia, Louisiana, Missouri, New York, South Carolina, Tennessee, Texas, and Wyoming. International distribution included Australia, Canada, Czechoslovakia, China, Colombia, France, Great Britain, Italy, Netherlands, Poland, Saudi Arabia, and Turkey. Affected serial numbers include "040-1565-10" and "063-1829-11".

The recalled product

Product
Spacelabs Healthcare G2 Clinical Access Mislabeled CDs for PN: 063-1829-11 Rev A and Update Kit, PN: 040-1565-10. Used for installing ICS G2 Clinical Access software onto hospital personal computers.

Distribution

Distributed nationwide across the United States.

The notice also names 10 states specifically: